Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma

Caroline E. Nunes‐Xavier(BioCruces Health research Institute), Rafael Pulido(Instituto Valenciano de Investigaciones Agrarias), José I. López(BioCruces Health research Institute), Jesús M. Cortés(Ikerbasque), Olaia Aurtenetxe(BioCruces Health research Institute), Ricardo López Almaraz(BioCruces Health research Institute), Asier Erramuzpe(BioCruces Health research Institute), Laura Zaldumbide(Hospital de Cruces)
Diagnostic Pathology
December 1, 2019
10.1186/s13000-019-0919-9
Cited by 17

Related Papers

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
|Cell|2018|883
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
|Cell|2018|680
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
|Cell|2018|565
Actomyosin-Mediated Cellular Tension Drives Increased Tissue Stiffness and β-Catenin Activation to Induce Epidermal Hyperplasia and Tumor Growth
|Cancer Cell|2011|544
PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif
|The EMBO Journal|1998|314